©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Dec 5, 2025; 16(4): 111082
Published online Dec 5, 2025. doi: 10.4292/wjgpt.v16.i4.111082
Published online Dec 5, 2025. doi: 10.4292/wjgpt.v16.i4.111082
Table 4 Changes in gut hormones under obesity conditions
| Hormone | Alteration in obesity | Response to weight loss | Ref. |
| GLP-1 | Blunted postprandial response, reduced levels | Diet reduces fasting levels, exercise may increase postprandial levels | [55] |
| Peptide YY | Attenuated postprandial response, lower levels | Diet decreases fasting levels, exercise may increase in some cases | [55] |
| Pancreatic polypeptide | Conflicting results, often lower fasting levels | Diet increases postprandial levels, sustained for 1 year | [55] |
| Cholecystokinin | Reduced postprandial levels post-weight loss | Diet reduces levels, exercise has minimal effect | [55] |
| Leptin | Higher baseline levels in obese individuals | Decreases significantly with diet (35% with 15% weight loss), sustained reduction | [55] |
| Ghrelin | Lower fasting/postprandial levels, less suppression post-meal | Increases with diet (17% with 4.5% weight loss), exercise enhances post-loss levels | [55] |
- Citation: Wang SY, Zhang MZ, Chen ZM, Li ZM, Xie CY, Yang GH, Xu B, Xu TC. Intestinal-related substances in obesity regulation: A comprehensive review. World J Gastrointest Pharmacol Ther 2025; 16(4): 111082
- URL: https://www.wjgnet.com/2150-5349/full/v16/i4/111082.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v16.i4.111082